💡Check out this in-depth interview with Dr. Daniel Vitt, CEO and President of Immunic, featured in Euro Health Leaders. Dr. Vitt shares valuable insights on his personal journey in the biotechnology space, Immunic's research and development pipeline, and what’s next in the field of multiple sclerosis. Read the full interview here: ➡️ https://bit.ly/4b8CWqu #EuroHealthLeaders #BiotechLeadership #HealthcareInnovation #biotechnology #biotech #MultipleSclerosis #MS #Immunic #IMUX
Dr. Daniel Vitt's insights in the interview are truly enlightening, shedding light on Immunic's impactful contributions in the biotechnology sector, particularly in multiple sclerosis research. His journey and Immunic's R&D pipeline showcase dedication to advancing healthcare innovation. #EuroHealthLeaders #BiotechLeadership #HealthcareInnovation #Biotechnology #MultipleSclerosis #IMUX
Thank you Immunic Therapeutics for your kind words of acknowledgement. It is an honour to feature Daniel Vitt, CEO and President of Immunic, in Euro Health Leaders magazine. His valuable insights in the biotechnology space are very enriching. We eagerly look forward to your regular participation.